Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing

Mitchell L. Leibowitz,Stamatis Papathanasiou,Phillip A. Doerfler,Logan J. Blaine,Lili Sun,Yu Yao,Cheng-Zhong Zhang,Mitchell J. Weiss,David Pellman

DOI: https://doi.org/10.1038/s41588-021-00838-7

IF: 30.8

2021-04-12

Nature Genetics

Abstract:Genome editing has therapeutic potential for treating genetic diseases and cancer. However, the currently most practicable approaches rely on the generation of DNA double-strand breaks (DSBs), which can give rise to a poorly characterized spectrum of chromosome structural abnormalities. Here, using model cells and single-cell whole-genome sequencing, as well as by editing at a clinically relevant locus in clinically relevant cells, we show that CRISPR–Cas9 editing generates structural defects of the nucleus, micronuclei and chromosome bridges, which initiate a mutational process called chromothripsis. Chromothripsis is extensive chromosome rearrangement restricted to one or a few chromosomes that can cause human congenital disease and cancer. These results demonstrate that chromothripsis is a previously unappreciated on-target consequence of CRISPR–Cas9-generated DSBs. As genome editing is implemented in the clinic, the potential for extensive chromosomal rearrangements should be considered and monitored.

genetics & heredity

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the potential genotoxicity that the CRISPR - Cas9 gene - editing technology may bring when treating genetic diseases, especially regarding the chromosomal structural abnormalities caused by DNA double - strand breaks (DSBs) generated during targeted gene - editing. Specifically, the research focuses on whether DNA breaks caused by CRISPR - Cas9 will lead to chromothripsis, which is a phenomenon of extensive chromosomal rearrangement limited to one or several chromosomes and is often accompanied by fluctuations in DNA copy number levels between two or three levels.

The researchers used multiple methods, including combining imaging techniques and single - cell whole - genome sequencing (Look - Seq), to explore nuclear structural defects that occur within cells after CRISPR - Cas9 gene - editing, such as micronucleus formation and the generation of chromosomal bridges, which may trigger chromothripsis. The research results show that CRISPR - Cas9 gene - editing can indeed lead to the formation of micronuclei containing the target chromosomal arms, and these micronuclei will experience extensive DNA damage in subsequent cell cycles and may ultimately lead to the occurrence of chromothripsis.

In addition, the study also explored the influence of the p53 state on whether cells containing micronuclei can undergo cell division and how these cells containing micronuclei can establish stable chromosomes in long - term culture, even after experiencing chromothripsis. These findings are of great significance for understanding the potential risks of the CRISPR - Cas9 gene - editing technology in clinical applications.